Evaluation of Microinjected Amnion-derived Collagen by Dermapen in the Smoothing of Skin Wrinkles
NCT ID: NCT06054646
Last Updated: 2023-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
20 participants
INTERVENTIONAL
2019-05-01
2021-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of J-Plasma® for Dermal Resurfacing
NCT03286283
Platelet Rich Fibrin Versus Platelet Rich Plasma for Microneedling Treatment of Facial Photoaging
NCT06452667
MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology
NCT07261748
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
NCT06021275
Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post-acne Scars: a Split-face
NCT06580691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Amnion Collagen
The right side of the split-face was treated by micro-injection of Amnion Collagen
Amnion collagen
A collagen extract sourced from the human amniotic membrane
PRP
The left side of the split-face was treated by micro-injection of Platelet-rich plasma (PRP)
Platelet-rich plasma
Autologous preparation of PRP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amnion collagen
A collagen extract sourced from the human amniotic membrane
Platelet-rich plasma
Autologous preparation of PRP
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who accepted to participate in this study.
Exclusion Criteria
36 Years
57 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Waleed Nemr,Egyptian Atomic Energy Authority
UNKNOWN
Egyptian Atomic Energy Authority
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nashwa Radwan
Head of amnion preparation laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Egyptain Atomic Energy Authority
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3122019NCRRT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.